ArticleFrontiers in nutrition2026
Assessment of safety profile and anti-obesity effects of innovative plant-based food formulations in a zebrafish diet-induced obesity model.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Obesity is a complex metabolic disorder associated with impaired glucose, lipid metabolism and excessive visceral fat accumulation. Therefore, the development of effective dietary strategies, including functional foods, has attracted increasing interest. This study aimed to evaluate the safety and the metabolic effects of three food formulations (F1, F2, and F3) using a zebrafish model. Methods: The safety profile of the complex of active substances was assessed in zebrafish embryos and larvae by evaluating survival, hatching rate, spontaneous movement, morphological abnormalities, and cardiac function. To investigate metabolic effects, diet-induced obesity was established in adult zebrafish. Results: Supplementation with F1, F2, or F3 did not toxicity or developmental defects at early life stages. It resulted in significant reductions in body weight, glucose, triglycerides, and total cholesterol levels compared to obese controls. Additionally, formulations reduced visceral fat content, while F1 and F2 also significantly decreased subcutaneous fat. Discussion: These findings demonstrate that the tested food formulations are safe and exert beneficial effects on metabolic parameters and fat accumulation in zebrafish. The results suggest their potential as functional dietary interventions contributing to the amelioration of diet-induced obesity-related metabolic dysfunction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.